Melbourne researchers have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.
The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukaemia.
Dr Ben Shields and Dr Matt McCormack from the Walter and Eliza Hall Institute’s Cancer and Haematology division discovered that loss of the Hhex protein put the handbrake on leukaemia cell growth and division. The protein is a critical factor enabling AML cells to grow uncontrollably, a hallmark of cancer.
AML is an aggressive blood cancer that appears suddenly, grows quickly and has a poor prognosis. Existing treatments for AML are associated with serious side-effects. About three quarters of patients relapse after only a short period of treatment, with a five-year survival rate of just 24 per cent.
Dr McCormack said discovering how AML overcame normal cellular controls on growth and division was a breakthrough in the search for new therapies.
“There is an urgent need for new therapies to treat AML,” said Dr McCormack. “We showed blocking the Hhex protein could put the brakes on leukaemia growth and completely eliminate AML in preclinical models. This could be targeted by new drugs to treat AML in humans.”
He said Hhex was a particularly attractive therapeutic target because it was overproduced in leukaemia and, while essential for leukaemia cell growth, was not needed by healthy blood cells.
“Most existing treatments for AML are not cancer cell-specific, and unfortunately kill off healthy cells in the process,” Dr McCormack said.
“Hhex is only essential for the leukaemic cells, meaning we could target and treat leukaemia without toxic effects on normal cells, avoiding many of the serious side-effects that come with standard cancer treatments. We also know that most people with AML have increased levels of Hhex, often associated with adverse outcomes, further indicating it is an important target for new AML drugs.”
Dr Shields said AML cells switched off the controls that strictly manage cell growth and division. “Every cell has control genes that are activated when a cell is stressed, such as in the early stages of cancer, and stop the damaged cell from reproducing.” Dr Shields said.
While these control genes are still present in AML cells, they are switched off through a process called epigenetic modification. “Hhex works by recruiting epigenetic factors to growth control genes, effectively silencing them. This allows the leukaemia cells to reproduce and accumulate more damage, contributing to the speed of AML progression,” Dr Shields said.
Dr McCormack said drugs that inhibit epigenetic modification had been previously used to treat AML, but caused significant toxicity because their targets were also required for normal blood cell function.
“Unlike the epigenetic factors targeted previously, Hhex only regulates a small number of genes and is dispensable for normal blood cells. This gives us a rare opportunity to kill AML cells without causing many side effects,” said Dr McCormack. “We now hope to identify the critical regions of the Hhex protein that enable it to function, which will allow us to design much-needed new drugs to treat AML.”
The Latest on: Leukaemia
via Google News
The Latest on: Leukaemia
- Mum, 35, who blamed cough and weight loss on stress discovers it’s actually sign of leukaemia on February 18, 2019 at 2:38 am
Louise Moreton was repeatedly told by her GP that she'd probably just picked up flu But after being told it was flu, the 35-year-old eventually went back to doctors after noticing she'd lost weight an... […]
- Mother, 35, discovers her cough that wouldn't shift is life-threatening LEUKAEMIA on February 17, 2019 at 6:59 pm
A young mother who thought her lingering cough was her body reacting to the stress of moving across the world was horrified to be told she actually had leukaemia. Louise Moreton, 35, who moved from Me... […]
- Little girl's 'dental issue' turns out to be leukaemia on February 16, 2019 at 8:51 pm
A six-year-old Queensland girl is battling leukaemia in hospital after a lump on her jaw was initially thought to be a dental issue. After Hunter’s family noticed a lump on her jaw, the little ... […]
- Girl is diagnosed with leukaemia after being told my doctors a lump on her jaw was a dental issue on February 16, 2019 at 8:04 pm
When Hunter complained of having a lump on her jaw, her and her family spent months in and out of doctors' offices in Maryborough, north of Brisbane. Each time she visited a doctor, the six-year-old w... […]
- Teen’s third fight to survive leukaemia on February 16, 2019 at 11:56 am
Just a few weeks ago 17-year-old Robbie Eddles was enjoying being back at school and basking in the fact he'd made it onto the basketball team. Now, he's bravely fighting cancer in a Durban hospital b... […]
- Israeli travel restrictions separate Palestinian girl with leukaemia from parents on February 16, 2019 at 7:34 am
7-year-old Mais has leukaemia and misses her mother. She was transferred from Gaza to a hospital in Bethlehem and due to Israeli restrictions on Palestinians, Mais' mother was not granted a travel per... […]
- School to hold stem cell tests for pupil with leukaemia on February 13, 2019 at 8:10 am
A school attended by a boy with leukaemia is holding stem cell donation swab tests in a bid to find a match. The parents of five-year-old Oscar Saxelby-Lee, from Worcester, said they were reliant on t... […]
- Japan’s swim star Ikee diagnosed with leukaemia on February 12, 2019 at 12:08 pm
Japanese swim queen Rikako Ikee, the poster girl for next year’s Tokyo Olympics, has been diagnosed with leukaemia, the 18-year-old tweeted yesterday. In a shock announcement, Ikee said: “After feelin... […]
- Swimming - Tokyo Olympics medal hopeful Ikee diagnosed with leukaemia on February 12, 2019 at 2:08 am
TOKYO (Reuters) - Japanese swimmer Rikako Ikee, who won six titles at last year’s Asian Games and was considered a strong medal contender for the 2020 Tokyo Olympics, said on Tuesday she had ... […]
- Rikako Ikee diagnosed with leukaemia after poster girl of Tokyo 2020 Olympic Games ‘felt ill’ on February 12, 2019 at 1:35 am
Rikako Ikee, the poster girl of the Tokyo 2020 Olympic Games, has revealed that she has been diagnosed with leukaemia. The 18-year-old Japanese swimmer was considered a strong medal favourite for the ... […]
via Bing News